103 related articles for article (PubMed ID: 1384147)
1. Bleomycin pulmonary toxicity: current status and future directions.
Comis RL
Semin Oncol; 1992 Apr; 19(2 Suppl 5):64-70. PubMed ID: 1384147
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary toxicity induced by pepleomycin 3-[(S)-1'-phenylethylamino] propylamino-bleomycin.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Shibuya M; Shimabukuro Z; Koketsu H; Nakajima T; Niitani H
Jpn J Clin Oncol; 1983 Jun; 13(2):395-410. PubMed ID: 6193296
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary function assessment during bleomycin therapy.
Lampert-Benignus E; Eichler-Reiss F; Meunier-Carius J; Keiling R
Biomed Pharmacother; 1985; 39(2):87-93. PubMed ID: 2410052
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of the pulmonary toxicity of continuously infused bleomycin.
Cooper KR; Hong WK
Cancer Treat Rep; 1981; 65(5-6):419-25. PubMed ID: 6165471
[TBL] [Abstract][Full Text] [Related]
5. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
6. Bleomycin and pulmonary toxicity.
Van Barneveld PW; Mulder NH; Van der Mark TW; Sleijfer DT
Neth J Med; 1985; 28(11):516-23. PubMed ID: 2417127
[No Abstract] [Full Text] [Related]
7. Assessment of pulmonary and hematologic toxicities of liblomycin, a novel bleomycin analog.
Newman RA; Siddik ZH; Travis EL; Followill D; Ayele W; Burditt T; Krakoff IH
Invest New Drugs; 1990 Feb; 8(1):33-41. PubMed ID: 1693138
[TBL] [Abstract][Full Text] [Related]
8. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
[TBL] [Abstract][Full Text] [Related]
9. Bleomycin pulmonary toxicity has a negative impact on the outcome of patients with Hodgkin's lymphoma.
Martin WG; Ristow KM; Habermann TM; Colgan JP; Witzig TE; Ansell SM
J Clin Oncol; 2005 Oct; 23(30):7614-20. PubMed ID: 16186594
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
[TBL] [Abstract][Full Text] [Related]
11. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
[TBL] [Abstract][Full Text] [Related]
12. [Cardiotoxicity and pulmonary toxicity of chemotherapy].
Okuma K; Ariyoshi Y; Ota K
Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):934-41. PubMed ID: 2188614
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary and systemic toxicity of bleomycin on severe combined immune deficiency mice.
Miyazawa H; Takiguchi Y; Hiroshima K; Kurosu K; Tada Y; Kasahara Y; Sakao S; Tanabe N; Tatsumi K; Kuriyama T
Exp Lung Res; 2008 Jan; 34(1):1-17. PubMed ID: 18205074
[TBL] [Abstract][Full Text] [Related]
14. Peplomycin and liblomycin, a new analogues of bleomycin.
Takita T; Ogino T
Biomed Pharmacother; 1987; 41(5):219-26. PubMed ID: 2444281
[TBL] [Abstract][Full Text] [Related]
15. Short- and long-term outcomes after large pulmonary resection for germ cell tumors after bleomycin-combination chemotherapy.
Andrade RS; Kesler KA; Wilson JL; Brooks JA; Reichwage BD; Rieger KM; Einhorn LH; Brown JW
Ann Thorac Surg; 2004 Oct; 78(4):1224-8; discussion 1228-9. PubMed ID: 15464475
[TBL] [Abstract][Full Text] [Related]
16. [Bleomycin and pulmonary function changes in children with malignant lymphomas].
Kuijten RR; Voûte PA; van Nierop JC; van Leeuwen EF; Griffioen RW; Wagner-Soeters RE
Ned Tijdschr Geneeskd; 1991 Feb; 135(6):225-8. PubMed ID: 1706483
[TBL] [Abstract][Full Text] [Related]
17. Fatal pulmonary bleomycin toxicity in cisplatin-induced acute renal failure.
Bennett WM; Pastore L; Houghton DC
Cancer Treat Rep; 1980; 64(8-9):921-4. PubMed ID: 6160913
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary toxicity of antineoplastic drugs.
Willson JK
Cancer Treat Rep; 1978 Dec; 62(12):2003-8. PubMed ID: 87268
[TBL] [Abstract][Full Text] [Related]
19. [Changes of anticancer activity and pulmonary toxicity of bleomycins in differences of administration schedules and routes in mice].
Ekimoto H; Takahashi K; Matsuda A; Umezawa H
Gan To Kagaku Ryoho; 1984 Apr; 11(4):853-7. PubMed ID: 6202241
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary toxicity studies of bleomycin and talisomycin.
Schlein A; Schurig JE; Baca C; Bradner WT; Crooks ST
Cancer Treat Rep; 1981; 65(3-4):291-7. PubMed ID: 6165468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
